Below are Sjögren’s Foundation Corporate Members with current or completed clinical trials for Sjögren’s disease in the United States. Click "Learn More" on each panel to view the trial associated with that Corporate Member. You can also use our clinical trial map or state listings to find trials by location, or visit ClinicalTrials.gov to explore all Sjögren’s disease trials.
Current/Ongoing Clinical Trials for Sjögren's Disease
These trials are open, actively enrolling, or in progress. Availability, locations, and eligibility criteria may vary.
Study Name:Unity - Efgartigimod
Phase: 3
Disease State: Moderate to severe systemic disease activity
Type: Systemic
Actively enrolling patients
Study Name:EnVISage - Sibeprenlimab
Phase: 2
Disease State: Moderate to severe systemic disease activity
Type: Systemic
Actively enrolling patients
Study Name: 132-06 Sjögren’s Study - RSLV-132
Phase: 2
Disease State: Moderate-to-high symptoms of fatigue, pain, and dryness
Type: Systemic
Actively enrolling patients
Study Name:OUTRACE Sjögren's
Phase: 1b
Disease State: Moderate to severe systemic disease activity
Type: Systemic
Actively enrolling patients
Study Name:DAFFODIL - Nipocalimab
Phase: 3
Disease State: Moderate to severe systemic disease activity
Type: Systemic
Active
Study Name:HZNP-DAZ-301 & HZNP-DAZ-303 - Dazodalibep
Phase: 3
Disease State: Moderate to severe systemic disease activity (301), moderate to severe symptom state (303)
Type: Systemic
Active not enrolling
Study Name:HZNP-HZN-1116-201
Phase: 2
Disease State: Moderate to high systemic disease activity (pop 1), moderate to severe subjective symptoms (pop 2)
Type: Systemic
Active not enrolling
Study Name:POETYK SjS-1 - Deucravacitinib
Phase: 3
Disease State: Moderate to severe systemic disease activity
Type: Systemic
Active not enrolling
Study Name:NEPTUNUS-1 & NEPTUNUS-2 - Ianalumab
Phase: 3
Disease State: Moderate to severe systemic disease activity
Type: Systemic
Active not enrolling
Historical/Completed Clinical Trials for Sjögren's Disease
These studies have ended but reflect ongoing research efforts and progress in developing new treatments.
Study Name:VIB4920 - Dazodalibep
Phase: 2
Disease State: Moderate to severe systemic disease activity; moderate to severe symptom state
Type: Systemic
Study Name:ARGX-113-2106 - Efgartigimod
Phase: 2
Disease State: Moderate to severe systemic disease activity
Type: Systemic
Study Name:DAHLIAS - Nipocalimab
Phase: 2
Disease State: Moderate to severe systemic disease activity
Type: Systemic
Study Name:VAY736 - ianalumab
Phase: 2b
Disease State: Moderate to severe systemic disease activity
Type: Systemic
Study Name:132-04 Sjogren's Study - RSLV-132
Phase: 2
Disease State: Sjögren's disease and positive interferon signature
Type: Systemic
Find a Clinical Trial
Explore clinical trials for Sjögren’s disease using our interactive map or state listings, and learn more about research opportunities near you.
Learn more